Insiders · SIOX

SIOX insider transactions

Sio Gene Therapies Inc. (SIOX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

SIOX insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Sio Gene Therapies Inc., latest first. Follow anyone to get their next filing.

• Parag V MeswaniOfficer, since January 2022
• David W. NassifOfficer, Director
• Pavan CheruvuOfficer, Director+$248K
• Kristiina MD VuoriDirector
• Frank TortiDirector
• Senthil Vel SundaramDirector
• Atul PandeDirector
• Berndt ModigDirector
• Gavin CorcoranOfficer

Recent Form 3, 4, and 5 filings for SIOX

• 1733d
  SEC Form 4 filed by Meswani Parag V

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 1733d
  SEC Form 4 filed by Nassif David W.

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 1736d
  SEC Form 3: New insider Meswani Parag V claimed ownership of 33,733 shares

  3 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 1796d
  SEC Form 4: Nassif David W. was granted 17,534 shares and covered exercise/tax liability with 6,294 shares, increasing direct ownership by 33% to 45,244 units (withholding obligation)

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 1796d
  SEC Form 4: Cheruvu Pavan was granted 37,567 shares and covered exercise/tax liability with 14,884 shares, increasing direct ownership by 13% to 203,109 units to cover taxes

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2030d
  SEC Form 4 filed by Vuori Kristiina MD

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2030d
  SEC Form 4 filed by Torti Frank

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2030d
  SEC Form 4 filed by Sundaram Senthil Vel

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2030d
  SEC Form 4 filed by Pande Atul

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2030d
  SEC Form 4 filed by Modig Berndt

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2030d
  SEC Form 4 filed by Nassif David W.

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2030d
  SEC Form 4 filed by Corcoran Gavin

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2030d
  SEC Form 4 filed by Cheruvu Pavan

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2056d
  SEC Form 4: Pavan Cheruvu bought $248,180 worth of Common Stock (100,000 units at $2.48), increasing direct ownership by 124% to 180,426 units

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2058d
  SEC Form 4: W. David Nassif was granted 15,060 units of Common Stock, increasing direct ownership by 79% to 34,004 units

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2061d
  SEC Form 4: Gavin Corcoran was granted 16,001 units of Common Stock, increasing direct ownership by 163% to 25,792 units

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)
• 2061d
  SEC Form 4: Pavan Cheruvu was granted 22,590 units of Common Stock, increasing direct ownership by 39% to 80,426 units

  4 - Sio Gene Therapies Inc. (0001636050) (Issuer)